FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
24/7 Wall St6h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...
Australian Broadcasting Corporation12h
New South Wales
The Waverley Council says it will consider taking actions after tens of thousands of people trashed Sydney's Bronte Beach following a massive Christmas party. Tens of thousands of people have ...
Greek Reporter21h
Greek News
Did social media kill love? What is love? Your grandmother, your father, your mother can all give an answer. They all have a definition in mind. Do you? If you are a Millennial or a Gen Z member you ...
Sleep apnea gets its first drug: Why US FDA approves weight loss drug for use
The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...